Literature DB >> 1833774

A minimal cascade model for the mitotic oscillator involving cyclin and cdc2 kinase.

A Goldbeter1.   

Abstract

A minimal model for the mitotic oscillator is presented. The model, built on recent experimental advances, is based on the cascade of post-translational modification that modulates the activity of cdc2 kinase during the cell cycle. The model pertains to the situation encountered in early amphibian embryos, where the accumulation of cyclin suffices to trigger the onset of mitosis. In the first cycle of the bicyclic cascade model, cyclin promotes the activation of cdc2 kinase through reversible dephosphorylation, and in the second cycle, cdc2 kinase activates a cyclin protease by reversible phosphorylation. That cyclin activates cdc2 kinase while the kinase triggers the degradation of cyclin has suggested that oscillations may originate from such a negative feedback loop [Félix, M. A., Labbé, J. C., Dorée, M., Hunt, T. & Karsenti, E. (1990) Nature (London) 346, 379-382]. This conjecture is corroborated by the model, which indicates that sustained oscillations of the limit cycle type can arise in the cascade, provided that a threshold exists in the activation of cdc2 kinase by cyclin and in the activation of cyclin proteolysis by cdc2 kinase. The analysis shows how miototic oscillations may readily arise from time lags associated with these thresholds and from the delayed negative feedback provided by cdc2-induced cyclin degradation. A mechanism for the origin of the thresholds is proposed in terms of the phenomenon of zero-order ultrasensitivity previously described for biochemical systems regulated by covalent modification.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1833774      PMCID: PMC52661          DOI: 10.1073/pnas.88.20.9107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Control of oscillating glycolysis of yeast by stochastic, periodic, and steady source of substrate: a model and experimental study.

Authors:  A Boiteux; A Goldbeter; B Hess
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

2.  A model for the adjustment of the mitotic clock by cyclin and MPF levels.

Authors:  R Norel; Z Agur
Journal:  Science       Date:  1991-03-01       Impact factor: 47.728

3.  Complementation of the mitotic activator, p80cdc25, by a human protein-tyrosine phosphatase.

Authors:  K L Gould; S Moreno; N K Tonks; P Nurse
Journal:  Science       Date:  1990-12-14       Impact factor: 47.728

4.  Cyclin is degraded by the ubiquitin pathway.

Authors:  M Glotzer; A W Murray; M W Kirschner
Journal:  Nature       Date:  1991-01-10       Impact factor: 49.962

5.  INH, a negative regulator of MPF, is a form of protein phosphatase 2A.

Authors:  T H Lee; M J Solomon; M C Mumby; M W Kirschner
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

6.  A Model Based on Receptor Desensitization for Cyclic AMP Signaling in Dictyostelium Cells.

Authors:  J L Martiel; A Goldbeter
Journal:  Biophys J       Date:  1987-11       Impact factor: 4.033

Review 7.  G1-specific cyclins: in search of an S-phase-promoting factor.

Authors:  S I Reed
Journal:  Trends Genet       Date:  1991-03       Impact factor: 11.639

8.  The cdc25 protein controls tyrosine dephosphorylation of the cdc2 protein in a cell-free system.

Authors:  A Kumagai; W G Dunphy
Journal:  Cell       Date:  1991-03-08       Impact factor: 41.582

9.  Dephosphorylation and activation of a p34cdc2/cyclin B complex in vitro by human CDC25 protein.

Authors:  U Strausfeld; J C Labbé; D Fesquet; J C Cavadore; A Picard; K Sadhu; P Russell; M Dorée
Journal:  Nature       Date:  1991-05-16       Impact factor: 49.962

10.  Cyclin B targets p34cdc2 for tyrosine phosphorylation.

Authors:  L Meijer; L Azzi; J Y Wang
Journal:  EMBO J       Date:  1991-06       Impact factor: 11.598

View more
  109 in total

1.  Modeling the fission yeast cell cycle: quantized cycle times in wee1- cdc25Delta mutant cells.

Authors:  A Sveiczer; A Csikasz-Nagy; B Gyorffy; J J Tyson; B Novak
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

2.  Quantitative analysis of bacterial gene expression by using the gusA reporter gene system.

Authors:  J Sun; I Smets; K Bernaerts; J Van Impe; J Vanderleyden; K Marchal
Journal:  Appl Environ Microbiol       Date:  2001-08       Impact factor: 4.792

3.  Tuning the cell cycle: a model based on averaging.

Authors:  Paul Frankel
Journal:  Cell Prolif       Date:  2002-12       Impact factor: 6.831

4.  Dynamics of the cell cycle: checkpoints, sizers, and timers.

Authors:  Zhilin Qu; W Robb MacLellan; James N Weiss
Journal:  Biophys J       Date:  2003-12       Impact factor: 4.033

5.  Hysteresis drives cell-cycle transitions in Xenopus laevis egg extracts.

Authors:  Wei Sha; Jonathan Moore; Katherine Chen; Antonio D Lassaletta; Chung-Seon Yi; John J Tyson; Jill C Sible
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-30       Impact factor: 11.205

6.  Circadian oscillations in period gene mRNA levels are transcriptionally regulated.

Authors:  P E Hardin; J C Hall; M Rosbash
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

7.  Multisite phosphorylation and network dynamics of cyclin-dependent kinase signaling in the eukaryotic cell cycle.

Authors:  Ling Yang; W Robb MacLellan; Zhangang Han; James N Weiss; Zhilin Qu
Journal:  Biophys J       Date:  2004-06       Impact factor: 4.033

8.  Gene dosage balance in cellular pathways: implications for dominance and gene duplicability.

Authors:  Reiner A Veitia
Journal:  Genetics       Date:  2004-09       Impact factor: 4.562

9.  Hybrid modeling and simulation of stochastic effects on progression through the eukaryotic cell cycle.

Authors:  Zhen Liu; Yang Pu; Fei Li; Clifford A Shaffer; Stefan Hoops; John J Tyson; Yang Cao
Journal:  J Chem Phys       Date:  2012-01-21       Impact factor: 3.488

10.  An automaton model for the cell cycle.

Authors:  Atilla Altinok; Didier Gonze; Francis Lévi; Albert Goldbeter
Journal:  Interface Focus       Date:  2010-11-24       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.